BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25679398)

  • 21. [Screening of differentially expressed proteins in serum from subjects with Keshan disease by two-dimensional electrophoresis and mass and mass spectrometry].
    He S; Tan W; Wang J; Wang P; Xiang Y
    Wei Sheng Yan Jiu; 2013 May; 42(3):424-8. PubMed ID: 23805519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards identification of novel putative biomarkers for infective endocarditis by serum proteomic analysis.
    Snipsøyr MG; Wiggers H; Ludvigsen M; Stensballe A; Vorum H; Poulsen SH; Rasmussen LM; Petersen E; Honoré B
    Int J Infect Dis; 2020 Jul; 96():73-81. PubMed ID: 32087365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics and pitfalls in the search for potential biomarkers of abdominal aortic aneurysms.
    Nordon IM; Brar R; Hinchliffe RJ; Cockerill G; Thompson MM
    Vascular; 2010; 18(5):264-8. PubMed ID: 20822720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
    Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM;
    Am J Kidney Dis; 2015 Jan; 65(1):49-57. PubMed ID: 25115616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple biomarkers of sepsis identified by novel time-lapse proteomics of patient serum.
    Hayashi N; Yamaguchi S; Rodenburg F; Ying Wong S; Ujimoto K; Miki T; Iba T
    PLoS One; 2019; 14(9):e0222403. PubMed ID: 31568522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential proteomic characterization between normal peritoneal fluid and diabetic peritoneal dialysate.
    Wang HY; Tian YF; Chien CC; Kan WC; Liao PC; Wu HY; Su SB; Lin CY
    Nephrol Dial Transplant; 2010 Jun; 25(6):1955-63. PubMed ID: 20054029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers identified from serum proteomic analysis for the differential diagnosis of systemic lupus erythematosus.
    Kazemipour N; Qazizadeh H; Sepehrimanesh M; Salimi S
    Lupus; 2015 May; 24(6):582-7. PubMed ID: 25391542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies for proteomics with incompletely characterized genomes: the proteome of Bos taurus serum.
    Wait R; Miller I; Eberini I; Cairoli F; Veronesi C; Battocchio M; Gemeiner M; Gianazza E
    Electrophoresis; 2002 Sep; 23(19):3418-27. PubMed ID: 12373772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential epithelial and stromal protein profiles in keratoconus and normal human corneas.
    Joseph R; Srivastava OP; Pfister RR
    Exp Eye Res; 2011 Apr; 92(4):282-98. PubMed ID: 21281627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
    Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
    Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged erythropoietin treatment does not impact gene expression in human skeletal muscle.
    Christensen B; Nellemann B; Thorsen K; Nielsen MM; Pedersen SB; Ornstrup MJ; JØrgensen JO; Jessen N
    Muscle Nerve; 2015 Apr; 51(4):554-61. PubMed ID: 25088500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia.
    Hernandez E; Ganly P; Charu V; Dibenedetto J; Tomita D; Lillie T; Taylor K;
    Curr Med Res Opin; 2009 Sep; 25(9):2109-20. PubMed ID: 19601709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma protein changes in horse after prolonged physical exercise: a proteomic study.
    Scoppetta F; Tartaglia M; Renzone G; Avellini L; Gaiti A; Scaloni A; Chiaradia E
    J Proteomics; 2012 Jul; 75(14):4494-504. PubMed ID: 22546489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the serum proteomes of pathological stages during hepatocarcinogenesis].
    Shu H; Kang XN; Li M; Guo K; Sun L; Li S; Xie L; Deng JH; Qin X; Liu YK
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):520-5. PubMed ID: 19912687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy-Related Changes in the Serum Proteome Patterns of Early Stage Breast Cancer Patients with Different Outcomes.
    Walaszczyk A; Pietrowska M; Wojakowska A; Abramowicz A; Chmura A; Maslyk B; Rodziewicz P; Polanska J; Behrendt K; Nowicka E; Tarnawski R; Widlak P
    Protein Pept Lett; 2017; 24(1):37-45. PubMed ID: 29366405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of potential serum biomarkers of inflammation and lipid modulation that are altered by fish oil supplementation in healthy volunteers.
    de Roos B; Geelen A; Ross K; Rucklidge G; Reid M; Duncan G; Caslake M; Horgan G; Brouwer IA
    Proteomics; 2008 May; 8(10):1965-74. PubMed ID: 18491311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic identification of plasma proteins as markers of growth promoter abuse in cattle.
    Kinkead RA; Elliott CT; Cannizzo FT; Biolatti B; Mooney MH
    Anal Bioanal Chem; 2015 Jun; 407(15):4495-507. PubMed ID: 25912459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Intensity Interval- vs Moderate Intensity- Training for Improving Cardiometabolic Health in Overweight or Obese Males: A Randomized Controlled Trial.
    Fisher G; Brown AW; Bohan Brown MM; Alcorn A; Noles C; Winwood L; Resuehr H; George B; Jeansonne MM; Allison DB
    PLoS One; 2015; 10(10):e0138853. PubMed ID: 26489022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic profiling identifies haptoglobin as a potential serum biomarker for steroid-resistant nephrotic syndrome.
    Wen Q; Huang LT; Luo N; Wang YT; Li XY; Mao HP; Zhang L; Dong XQ; Yu XQ
    Am J Nephrol; 2012; 36(2):105-13. PubMed ID: 22759352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markedly increased urinary preprohaptoglobin and haptoglobin in passive Heymann nephritis: a differential proteomics approach.
    Ngai HH; Sit WH; Jiang PP; Thongboonkerd V; Wan JM
    J Proteome Res; 2007 Aug; 6(8):3313-20. PubMed ID: 17616219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.